Multiple Disease Sites

  • NCI-Match / EAY131 Targeted Therapy Directed by genetic testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma

  • S1609: Nivolumab and Ipilimumab in treating rare tumors

For more information, contact Mia Johnson, RN, BSN at 360-788-8240